EAMAN ALHAIDER: Open Payments
NPI 1578948220 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 15 payments from 11 companies in 2025. Trend: 2023 $124 · 2024 $168 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: BREZTRI, Veozah, JARDIANCE, Kerendia, TZIELD, EVENITY, GEMTESA, Korlym.
Industry payments across MI — which companies pay providers there.
